|
Rimonabant (Acomplia, Zimulti) represents a novel way of controlling body weight. It operates by being a cannabinoid receptor antagonist.
The active ingredient in Acomplia is rimonabant. Rimonabant works by blocking specific receptors in the brain and the fat tissues called “CB1” receptors. This means that Acomplia (rimonabant) prevents the normal action of the natural levels of cannabinoid in the brain from stimulating these CB1 receptors. It is believed that these receptors stimulate appetite and therefore when they are blocked, the desire to eat and so consumption of food is reduced. Put simply Acomplia (rimonabant) suppresses appetite signals from the brain and fatty tissue that promotes eating.
Rimonabant comes as a tear drop shaped, white film coated tablet with “20”punched into one side. It is an oral tablet which is swallowed.
|
